Meeder Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-269
| Closed | -$3.38K | – | 1020 |
|
|
2024
Q4 | $3.38K | Buy |
+269
| New | +$3.38K | ﹤0.01% | 869 |
|
|
2024
Q3 | – | Sell |
-178
| Closed | -$3.83K | – | 934 |
|
|
2024
Q2 | $3.83K | Buy |
+178
| New | +$3.83K | ﹤0.01% | 805 |
|
|
2021
Q4 | – | Sell |
-4,221
| Closed | -$127K | – | 2068 |
|
|
2021
Q3 | $127K | Buy |
4,221
+3,453
| +450% | +$104K | 0.01% | 839 |
|
|
2021
Q2 | $34K | Buy |
768
+83
| +12% | +$3.67K | ﹤0.01% | 1270 |
|
|
2021
Q1 | $30K | Buy |
+685
| New | +$30K | ﹤0.01% | 1284 |
|
|
2020
Q4 | – | Sell |
-556
| Closed | -$12K | – | 2154 |
|
|
2020
Q3 | $12K | Buy |
+556
| New | +$12K | ﹤0.01% | 1322 |
|
|
2020
Q2 | – | Sell |
-147
| Closed | -$2K | – | 2387 |
|
|
2020
Q1 | $2K | Buy |
147
+52
| +55% | +$707 | ﹤0.01% | 2112 |
|
|
2019
Q4 | $2K | Sell |
95
-7,426
| -99% | -$156K | ﹤0.01% | 2046 |
|
|
2019
Q3 | $88K | Buy |
+7,521
| New | +$88K | 0.01% | 846 |
|
|
2018
Q1 | – | Sell |
-394
| Closed | -$4K | – | 1715 |
|
|
2017
Q4 | $4K | Sell |
394
-372
| -49% | -$3.78K | ﹤0.01% | 1377 |
|
|
2017
Q3 | $5K | Buy |
766
+608
| +385% | +$3.97K | ﹤0.01% | 1274 |
|
|
2017
Q2 | $1K | Hold |
158
| – | – | ﹤0.01% | 1543 |
|
|
2017
Q1 | $1K | Sell |
158
-42
| -21% | -$266 | ﹤0.01% | 1544 |
|
|
2016
Q4 | $5K | Buy |
+200
| New | +$5K | ﹤0.01% | 859 |
|